161 related articles for article (PubMed ID: 8238263)
21. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
22. Expression and function of NJ-1 surface antigen in megakaryopoiesis.
Tang H; Zhang XQ; Naruse T; Ohbo K; Suda T
Biochem Biophys Res Commun; 2002 Apr; 292(3):667-74. PubMed ID: 11922618
[TBL] [Abstract][Full Text] [Related]
23. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin].
Ma DC; Jin BQ; Sun YH; Chang KZ; Dai B; Chu JJ; Liu YG
Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209
[TBL] [Abstract][Full Text] [Related]
24. Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes.
Nurden P; Nurden A
C R Acad Sci III; 1996 Aug; 319(8):717-26. PubMed ID: 8949396
[TBL] [Abstract][Full Text] [Related]
25. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
26. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
27. Glycoprotein I identification during normal and pathological megakaryocytic maturation.
Breton-Gorius J; Vanhaeke D; Tabilio A; Vainchenker W; Deschamps JF; Xu FS
Blood Cells; 1983; 9(2):275-91. PubMed ID: 6229299
[TBL] [Abstract][Full Text] [Related]
28. [Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
Caen JP; Cramer EM; Rendu F; Bryckaert M; Dupuy E; Levy-Toledano S
Bull Acad Natl Med; 1991 Oct; 175(7):1145-52; discussion 1152-3. PubMed ID: 1809489
[TBL] [Abstract][Full Text] [Related]
29. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
Fock EL; Yan F; Pan S; Chong BH
Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural analysis of megakaryocytes in GPV knockout mice.
Poujol C; Ramakrishnan V; DeGuzman F; Nurden AT; Phillips DR; Nurden P
Thromb Haemost; 2000 Aug; 84(2):312-8. PubMed ID: 10959706
[TBL] [Abstract][Full Text] [Related]
32. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.
Villeneuve J; Block A; Le Bousse-Kerdilès MC; Lepreux S; Nurden P; Ripoche J; Nurden AT
Exp Hematol; 2009 Jul; 37(7):849-56. PubMed ID: 19410025
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of endomitosis in primary murine megakaryocytes.
Carow CE; Fox NE; Kaushansky K
J Cell Physiol; 2001 Sep; 188(3):291-303. PubMed ID: 11473355
[TBL] [Abstract][Full Text] [Related]
34. Increased production of megakaryocytes near purity from cord blood CD34+ cells using a short two-phase culture system.
Boyer L; Robert A; Proulx C; Pineault N
J Immunol Methods; 2008 Mar; 332(1-2):82-91. PubMed ID: 18234208
[TBL] [Abstract][Full Text] [Related]
35. Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis.
Garimella R; Kacena MA; Tague SE; Wang J; Horowitz MC; Anderson HC
J Histochem Cytochem; 2007 Jul; 55(7):745-52. PubMed ID: 17371937
[TBL] [Abstract][Full Text] [Related]
36. [In vitro growth characteristics of rIL3 stimulated megakaryocytic progenitor cells (CFU-MK) of fetal liver].
Ma DC; Sun YH; Chang KZ
Sheng Li Xue Bao; 1997 Apr; 49(2):215-20. PubMed ID: 9812860
[TBL] [Abstract][Full Text] [Related]
37. The response of megakaryocytes with processes to thrombin.
Radley JM; Hartshorn MA; Green SL
Thromb Haemost; 1987 Aug; 58(2):732-6. PubMed ID: 3672424
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural megakaryocyte modifications after vanadium inhalation in spleen and bone marrow.
Fortoul TI; González-Villalva A; Piñón-Zarate G; Rodríguez-Lara V; Montaño LF; Saldivar-Osorio L
J Electron Microsc (Tokyo); 2009 Dec; 58(6):375-80. PubMed ID: 19567481
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.
Li J; Luo J; Luo YQ; Zhou M; Zhao L; Yao LJ; Dong H; Yang RN
Transfusion; 2014 Aug; 54(8):2106-17. PubMed ID: 24655355
[TBL] [Abstract][Full Text] [Related]
40. Scanning electron microscopy of cultured human megakaryocytes.
Chen S; Barnhart MI
Scan Electron Microsc; 1984; (Pt 1):291-301. PubMed ID: 6740231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
